United States · FDA National Drug Code directory
Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-7787_1eb8fb70-8c33-4b10-9ad5-301abe0af9a4
- Product NDC
- 68788-7787
- Form
- SUSPENSION
- Composition / generic term
- neomycin and polymyxin B sulfates and hydrocortisone otic
- Labeler
- Preferred Pharmaceuticals, Inc.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20201021
- Source listing expiry
- 20271231
Source-listed ingredients
- HYDROCORTISONE — 10 mg/mL
- NEOMYCIN SULFATE — 3.5 mg/mL
- POLYMYXIN B SULFATE — 10000 [USP'U]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (68788-7787-1) / 10 mL in 1 BOTTLE · 68788-7787-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →